First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis

Clinical trial NCT04798235 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04798235
Sponsor: Dr. Anupam Sehgal
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Infantile GM2 Gangliosidosis (Disorder)

Start date: 2021-03-12
Primary completion: 2027-03-12
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.